Pharmacogenomics and Personalized Treatment
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Pharmacogenetics".
Deadline for manuscript submissions: 10 November 2025 | Viewed by 41
Special Issue Editors
2. Division for Pharmacogenomics and Therapy Individualization, Department of Laboratory Diagnostics, University Hospital Centre Zagreb, 10000 Zagreb, Croatia
Interests: pharmacogenetics; pharmacogenomics; gene–drug interactions; adverse drug reactions; molecular medicine
Interests: pharmacogenetics; pharmacogenomics; gene-drug interactions; adverse drugs reactions; molecular medicine
Special Issue Information
Dear Colleagues,
The Special Issue titled “Pharmacogenomics and Personalized Treatment” investigates the rapidly growing field of pharmacogenomics, focusing on how genetic variations affect drug efficacy and toxicity, with significant implications for the development of personalized treatment strategies. This Special Issue will emphasize key research areas, including gene-drug interactions, pharmacogenomic biomarkers, ethical, legal, and social implications, and AI and machine learning in pharmacogenomics, to facilitate the integration of genetic data into clinical practice, leading to more effective, safe, and individualized treatments for patients.
The aim of this issue is to stimulate discussion on the integration of pharmacogenomic data into routine clinical practice while addressing the challenges associated with their implementation.
We encourage submissions that explore innovative methodologies, case studies, and those examining the future of pharmacogenomics in the modeling of personalized healthcare settings.
Dr. Livija Šimičević
Dr. Lana Ganoci
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmacogenomics
- personalized treatment
- genetic biomarkers
- drug metabolism
- gene–drug interactions
- genetic variation
- clinical pharmacogenomics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
